Rallybio Corp (Nasdaq:RLYB)
Health Care/Life Sciences • Pharmaceuticals
CIK 1739410
Company
Rallybio Corp. engages in the identification, research and development, and manufacture of clinical biotechnology products and therapies for severe and rare diseases. Its product candidates focus on the areas of fetal and neonatal disorders, hematology, immuno-inflammation, and metabolic disease. The company was founded by Martin W. Mackay, Stephen Uden, and Jeffrey M. Fryer in January 2018 and is headquartered in New Haven, CT.
Address
234 Church Street
Suite 1020
New Haven, Connecticut 06510
234 Church Street
Suite 1020
New Haven, Connecticut 06510
Employees
43
43
Stock Info
Close
$0.6960
$0.6960
Day Range
0.6905 - 0.7316
0.6905 - 0.7316
52 Week Range
0.6800 - 3.4600
0.6800 - 3.4600
Average volume
82.36K
82.36K
Short Interest
331.09K (02/14/25)
331.09K (02/14/25)
% of Float Shorted
1.62%
1.62%
Market Cap
$28.88M
$28.88M
Revenue
N/A
N/A
Net Income
-$74.56M
-$74.56M
2020 Sales Growth
N/A
N/A
Key Executives
Board Of Directors
Chairman Martin W. MacKay |
President, Chief Executive Officer & Director Stephen Uden |
Director Christine A. Nash |
Director Liu Hui |
Director Wendy K. Chung |
Independent Director Ronald M. Hunt |
Independent Director Helen Marie Boudreau |
Independent Director Robert L. Hopfner |
Independent Director Lucian Iancovici |
Lead Independent Director Paula Soteropoulos |
SEC filings
Date | Form | Event |
---|---|---|
12 Nov, 2024 | SC 13G/A | |
7 Nov, 2024 | 10-Q | |
7 Nov, 2024 | 8-K | |
17 Sep, 2024 | 8-K | |
8 Aug, 2024 | 8-K | |
8 Aug, 2024 | 10-Q | |
30 Jul, 2024 | SC 13G | |
30 Jul, 2024 | SC 13G/A | |
23 Jul, 2024 | 8-K | |
21 May, 2024 | 8-K | |
20 May, 2024 | EFFECT | |
17 May, 2024 | 4 | |
17 May, 2024 | 4 | |
17 May, 2024 | 4 | |
17 May, 2024 | 4 | |
17 May, 2024 | 4 | |
17 May, 2024 | 4 | |
17 May, 2024 | 4 | |
17 May, 2024 | 4 | |
16 May, 2024 | CORRESP | |
16 May, 2024 | UPLOAD | |
10 May, 2024 | S-3 | |
9 May, 2024 | 10-Q | |
9 May, 2024 | 8-K | |
22 Apr, 2024 | D | |
11 Apr, 2024 | DEF 14A | |
10 Apr, 2024 | 8-K | |
13 Mar, 2024 | S-8 | |
12 Mar, 2024 | 10-K | |
12 Mar, 2024 | 8-K | |
16 Feb, 2024 | 4 | |
16 Feb, 2024 | 4 | |
16 Feb, 2024 | 4 | |
16 Feb, 2024 | 4 | |
14 Feb, 2024 | SC 13G/A | |
12 Feb, 2024 | SC 13D/A | |
9 Feb, 2024 | SC 13G/A | |
6 Feb, 2024 | 8-K | |
4 Jan, 2024 | 4 | |
4 Jan, 2024 | 4 | |
2 Jan, 2024 | SC 13G/A | |
20 Dec, 2023 | 8-K | |
9 Nov, 2023 | 8-K | |
9 Nov, 2023 | 10-Q | |
8 Aug, 2023 | 10-Q | |
8 Aug, 2023 | 8-K | |
29 Jun, 2023 | 8-K | CEO Change |
22 May, 2023 | 8-K | |
19 May, 2023 | 4 | |
19 May, 2023 | 4 | |
19 May, 2023 | 4 | |
19 May, 2023 | 4 | |
19 May, 2023 | 4 | |
19 May, 2023 | 4 | |
19 May, 2023 | 4 | |
19 May, 2023 | 4 | |
12 May, 2023 | EFFECT | |
12 May, 2023 | 424B3 | |
11 May, 2023 | CORRESP | |
11 May, 2023 | UPLOAD | |
10 May, 2023 | S-8 | |
9 May, 2023 | 10-Q | |
9 May, 2023 | S-3 | |
9 May, 2023 | 8-K | |
10 Apr, 2023 | DEF 14A | |
16 Mar, 2023 | 4 | |
9 Mar, 2023 | 4 | |
9 Mar, 2023 | 4 | |
6 Mar, 2023 | 8-K | |
6 Mar, 2023 | 10-K | |
9 Feb, 2023 | SC 13G/A | |
6 Feb, 2023 | 4 | |
6 Feb, 2023 | SC 13G/A | |
6 Feb, 2023 | 4 | |
6 Feb, 2023 | 4 | |
1 Feb, 2023 | 4 | |
1 Feb, 2023 | 3 | |
1 Feb, 2023 | SC 13G/A | |
31 Jan, 2023 | 8-K | |
23 Jan, 2023 | SC 13G/A | |
5 Jan, 2023 | 4 | |
5 Jan, 2023 | 4 | |
5 Jan, 2023 | 4 | |
5 Jan, 2023 | 4 | |
1 Dec, 2022 | 8-K | |
17 Nov, 2022 | SC 13G | |
17 Nov, 2022 | 4 | |
14 Nov, 2022 | 8-K | |
14 Nov, 2022 | 424B5 | |
10 Nov, 2022 | 424B5 | |
7 Nov, 2022 | 10-Q | |
7 Nov, 2022 | 8-K | |
28 Sep, 2022 | 8-K | |
15 Aug, 2022 | EFFECT | |
15 Aug, 2022 | 424B5 | |
11 Aug, 2022 | UPLOAD | |
11 Aug, 2022 | CORRESP | |
8 Aug, 2022 | S-3 | |
8 Aug, 2022 | 10-Q | |
8 Aug, 2022 | 8-K | |
3 Aug, 2022 | 4 | |
3 Aug, 2022 | 3 | |
2 Aug, 2022 | 8-K | |
7 Jun, 2022 | 4 | |
7 Jun, 2022 | 4 | |
7 Jun, 2022 | SC 13D/A | |
6 Jun, 2022 | S-8 | |
2 Jun, 2022 | 8-K | |
27 May, 2022 | 8-K | |
26 May, 2022 | 4 | |
26 May, 2022 | 4 | |
26 May, 2022 | 4 | |
26 May, 2022 | 4 | |
26 May, 2022 | 4 | |
26 May, 2022 | 4 | |
26 May, 2022 | 4 | |
25 May, 2022 | 4 | |
25 May, 2022 | 4 | |
10 May, 2022 | 8-K | |
10 May, 2022 | 10-Q | |
25 Apr, 2022 | DEF 14A | |
6 Apr, 2022 | 4 | |
6 Apr, 2022 | 3 | |
6 Apr, 2022 | 3 | |
6 Apr, 2022 | 4 | |
4 Apr, 2022 | 8-K | |
23 Mar, 2022 | 4 | |
15 Mar, 2022 | 8-K | |
15 Mar, 2022 | 10-K | |
7 Mar, 2022 | 8-K | |
14 Feb, 2022 | SC 13G/A | |
11 Feb, 2022 | SC 13G | |
10 Feb, 2022 | 4 | |
10 Feb, 2022 | 4 | |
9 Feb, 2022 | 4 | |
9 Feb, 2022 | 4 | |
9 Feb, 2022 | 4 | |
9 Feb, 2022 | 4 | |
8 Feb, 2022 | SC 13G | |
21 Jan, 2022 | SC 13G | |
21 Jan, 2022 | 4 | |
18 Jan, 2022 | SC 13D/A | |
14 Jan, 2022 | 4 | |
12 Jan, 2022 | 4 | |
11 Jan, 2022 | 4 | |
5 Jan, 2022 | 4 | |
5 Jan, 2022 | 4 | |
5 Jan, 2022 | 4 | |
5 Jan, 2022 | 4 | |
5 Jan, 2022 | 4 | |
10 Nov, 2021 | 8-K | |
10 Nov, 2021 | 10-Q | |
9 Sep, 2021 | 8-K | |
9 Sep, 2021 | 10-Q | |
12 Aug, 2021 | SC 13D | |
12 Aug, 2021 | SC 13D | |
12 Aug, 2021 | SC 13D | |
9 Aug, 2021 | SC 13G | |
4 Aug, 2021 | 4 | |
4 Aug, 2021 | 4 | |
4 Aug, 2021 | 4 | |
4 Aug, 2021 | 4 | |
4 Aug, 2021 | 4 | |
4 Aug, 2021 | 4 | |
4 Aug, 2021 | 3/A | |
4 Aug, 2021 | SC 13G | |
2 Aug, 2021 | S-8 | |
2 Aug, 2021 | 8-K | |
2 Aug, 2021 | 4 | |
30 Jul, 2021 | 424B4 | IPO completed |
29 Jul, 2021 | 3 | |
29 Jul, 2021 | 3 | |
29 Jul, 2021 | 3 | |
29 Jul, 2021 | 3 | |
29 Jul, 2021 | 3 | |
29 Jul, 2021 | 3 | |
29 Jul, 2021 | 3 | |
29 Jul, 2021 | 3 | |
29 Jul, 2021 | 3 | |
29 Jul, 2021 | 3 | |
29 Jul, 2021 | 3 | |
29 Jul, 2021 | 3 | |
29 Jul, 2021 | 3 | |
29 Jul, 2021 | 3 | |
29 Jul, 2021 | CERT | |
29 Jul, 2021 | 8-A12B | |
28 Jul, 2021 | EFFECT | |
28 Jul, 2021 | SEC STAFF | |
28 Jul, 2021 | S-1MEF | |
26 Jul, 2021 | CORRESP | |
26 Jul, 2021 | CORRESP | |
22 Jul, 2021 | S-1/A | |
12 Jul, 2021 | CORRESP | |
2 Jul, 2021 | S-1 | |
7 Jun, 2021 | DRS/A | |
7 Jun, 2021 | DRSLTR | |
24 May, 2021 | UPLOAD | |
13 May, 2021 | SEC STAFF | |
27 Apr, 2021 | DRS |
Last update:2025-03-06 13:15:26.987751
Sign Up to Subscribe
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.